Close Menu

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories and Inpeco today announced a deal to build interfaces between Bio-Rad's clinical diagnostics platforms and Inpeco's FlexLab system.

The deal covers Bio-Rad's systems for diabetes, autoimmune disease, and infectious disease testing, and aims to provide clinical diagnostics labs "a complete and integrated solution that automates sample processing, consolidates testing platforms, and improves operating efficiency of the instruments," the partners said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.